Canadian paediatricians' opinions on rotavirus vaccination

Vaccine

Volumn 29, Issue 17, 2011, Pages 3177-3182

  Dube E ^a,b,c   Gilca, V ^a,b,c   Sauvageau, C ^a,b,c   Bradet, R ^b   Bettinger, J A ^d,e   Boulianne, N ^a,b,c   Boucher, F D ^b   McNeil, S ^f   Gemmill, I ^g   Lavoie, F ^b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e BC CHILDREN S HOSPITAL   (Canada)

^f Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

^g Kingston   (Canada)

Author keywords

Attitudes; Beliefs; Knowledge; Paediatricians; Rotavirus; Vaccination

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CANADA; DEHYDRATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROENTERITIS; HEALTH BELIEF MODEL; HOSPITALIZATION; HUMAN; IMMUNIZATION; MALE; NONHUMAN; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; ROTAVIRUS; ROTAVIRUS INFECTION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 79954585124     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.044     Document Type: Article

References (41)

1. WHO Rotavirus vaccines. Wkly Epidemiol Rec 2007, 82:285-296.
2. Cortese M.M., Parashar U.D. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58 (RR-2):1-25.
3. Rivest P., Proulx M., Lonergan G., Lebel M.H., Bedard L. Hospitalisations for gastroenteritis: the role of rotavirus. Vaccine 2004, 22(15-16):2013-2017.
4. Chang H.G., Glass R.I., Smith P.F., Cicirello H.G., Holman R.C., Morse D.L. Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J 2003, 22(9):808-814.
5. Clark H.F., Offit P.A. Rotavirus vaccines. Vaccines 1994, 809-822. W.B. Saunders Company, Philadelphia. S.A. Plotkin, E.A.J. Mortimer (Eds.).
6. Sénécal M., Brisson M., Lebel M., Yaremko J., Wong R., Gallant L.A., et al. Measuring the impact of rotavirus acute gastroenteritis episodes (MIRAGE): a prospective community-based study. Can J Infect Dis Med Microbiol 2008, 19(6):397-404.
7. Le Saux N., Bettinger J.A., Halperin S.A., Vaudry W., Scheifele D.W. Substantial morbidity for hospitalized children with community acquired rotavirus infections: 2005-2007 impact surveillance in canadian hospitals. Pediatr Infect Dis J 2010.
8. National Advisory Comittee on Immunization Updated statement on the use of rotavirus vaccines. CCDR RMTC 2010, 36(ACS-4):1-37.
9. Senecal M., Brisson M., Charrois G., The burden of rotavirus associated gastroenteritis in young Canadian children: a cohort model. Canadian Public Health Association; May 2006. 97th Annual Conference (Vancouver).
10. Ford-Jones E.L., Wang E., Petric M., Corey P., Moineddin R., Fearon M. Hospitalization for community-acquired, rotavirus-associated diarrhea. Arch Pediatr Adolesc Med 2000, 154(6):578-585.
11. Jacobs P., Shane L.G., Fassbender K., Wang E.L., Moineddin R., Ford-Jones E.L. Economic analysis of rotavirus-associated diarrhea in the metropolitan Toronto and Peel regions of Ontario. Can J Infect Dis 2002, 13(3):167-174.
12. Brisson M., Senecal M., Drolet M., Mansi J.A. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J 2010, 29(1):73-75.
13. NACI, Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine. National Advisory Committee on Immunization. CCDR-RMTC 2008; 34(1): 33.
14. Erickson L.J., De Wals P., Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005, 23(19):2470-2476.
15. Kempe A., Daley M.F., Parashar U.D., Crane L.A., Beaty B.L., Stokley S., et al. Will pediatricians adopt the new rotavirus vaccine?. Pediatrics 2007, 119(1):1-10.
16. Iwamoto M., Saari T.N., McMahon S.R., Yusuf H.R., Massoudi M.S., Stevenson J.M., et al. A survey of pediatricians on the reintroduction of a rotavirus vaccine. Pediatrics 2003, 112(1):6-10.
17. Patel M.M., Janssen A.P., Tardif R., Herring M., Parashar U. A qualitative assessment of factors influencing acceptance of new rotavirus vaccine among health care providers and consumers. BMC Pediatr 2007, 7:p32.
18. McPhillips H.A., Davis R.L., Marcuse E.K., Taylor J.A. The rotavirus vaccine's withdrawal and physicians' trust in vaccine safety mechanisms. Arch Pediatr Adolesc Med 2001, 155(9):1051-1056.
19. 2008 MD Select National - PinPointer CD-ROM. Canadian Medical Directory. Scott's Directories. Online: http://www.mdselect.com/.
20. Rosenstock I.M. The health belief model: explaining health behavior through expectancies. Health behavior and health education-theory research and practice 1991, 39-62. Jossey-Bass Publishers, San Francisco, CA. K.L. Glanz, F.M. Lewis, B.K. Rimer (Eds.).
21. Public Health Agency of Canada Canadian human papillomavirus vaccine research priorities workshop - final report. CCDR 2005, 32S1:66.
22. Comité sur l'immunisation du Québec, Prévention par la vaccination des maladies attribuables aux virus du papillome humain, Institut national de santé publique du Québec: Québec; 2007 p. 76.
23. Dubé E., Gilca V., Sauvageau C., Boulianne N., Boucher F., Bettinger J.A., et al., Setting priorities for new vaccination programs by using paediatricians' and family physicians' opinions. Poster presentation. 28th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). Nice, France; May 4-8, 2010.
24. Nunnally J.C., Bernstein I.H. Psychometric theory 1994, McGrawHill, New York. 3rd ed.
25. Schmitt H.J., Booy R., Aston R., Van Damme P., Schumacher R.F., Campins M., et al. How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Med 2007, 5:p11.
26. Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E., Allen B. Chapter 24: psychosocial aspects of vaccine acceptability. Vaccine 2006, 24(Suppl. 3):S201-S209.
27. Lagarde F. Summary of public opinion on immunization in Canada 2005, Public Health Agency of Canada, p. 19.
28. Daley M.F., Liddon N., Crane L.A., Beaty B.L., Barrow J., Babbel C., et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 2006, 118(6):2280-2289.
29. Posfay-Barbe K.M., Heininger U., Aebi C., Desgrandchamps D., Vaudaux B., Siegrist C.A. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics 2005, 116:623-633.
30. Ritvo P., Irvine J., Klar N., Wilson K., Brown L., Bremner K.E., et al. A Canadian national survey of attitudes and knowledge regarding preventive vaccines. J Immune Ther Vaccines 2003, 1(1):3.
31. Kempe A., Patel M.M., Daley M.F., Crane L.A., Beaty B., Stokley S., et al. Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States. Pediatrics 2009, 124(5):pe809-pe816.
32. Duval B., Gilca V., McNeil S., Dobson S., Money D., Gemmill I.M., et al. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 2007, 25(45):7841-7847.
33. Gilca V., Boulianne N., Dube E., Sauvageau C., Ouakki M. Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire survey. Int J Nurs Stud 2009, 46(9):1219-1235.
34. Dubé E., Gilca V., Sauvageau C., Boulianne N., Boucher F., Bettinger J.A., et al., Determinants of Canadian physicians' intention to recommend rotavirus vaccines. Poster presentation. 28th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Nice, France. May 4-8, 2010.
35. Boulianne N., Bradet R., Audet D., Deceuninck G. Enquête sur la couverture vaccinale des enfants de 1 an et 2ans au Québec en 2008 2009, Institut national de santé publique du Québec, Québec, p. 1-205.
36. Goodman A., Infant rotavirus vaccine reduces diarrhea-related hospitalizations, ed visits, and outpatients visits. Infectious Diseases Society of America (IDSA). 47th Annual Meeting: Abstracts LB-35, 1149, 1161. Presented October 31, 2009.
37. Victor J.C., Brewster J.M., Ferrence R., Ashley M.J., Cohen J.E., Selby P. Tobacco-related medical education and physician interventions with parents who smoke: survey of Canadian family physicians and pediatricians. Can Family Physician 2010, 56(2):157-163.
38. Nexoe J., Kragstrup J., Sogaard J. Decision on influenza vaccination among the ederly. A questionnaire study based on the health belief model and the multidimensional locus of control theory. Scand J Prim Health Care 1999, 17:106-110.
39. Brewer N.T., Chapman G.B., Gibbons F.X., Gerrard M., McCaul K.D., Weinstein N.D. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol 2007, 26(2):136-145.
40. Daley M.F., Crane L.A., Beaty B.L., Barrow J., Pearson K., Stevenson J.M., et al. Provider adoption of pneumococcal conjugate vaccine and the impact of vaccine shortages. Ambul Pediatr 2005, 5(3):157-164.
41. De Wals P., Boulianne N., Sevin E., Ouakki M., Deceuninck G., Guay M. Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programs. Can J Public Health 2009, 100(6):413-416.